Literature DB >> 21061151

Fasudil mesylate protects PC12 cells from oxidative stress injury via the Bax-mediated pathway.

Qin Li1, Dong Liu, Xianju Huang, Lianjun Guo.   

Abstract

We previously reported that fasudil mesylate (FM) improves neurological deficit and neuronal damage in rats with ischemia following middle cerebral artery occlusion and reperfusion in vivo. In this study, the properties of FM on hydrogen peroxide (H(2)O(2))-induced oxidative stress insult in cultured PC12 cells as well as the underlying mechanisms were investigated in vitro. Pretreatment with FM (5, 10 μM) prior to H(2)O(2) exposure significantly elevated cell viability, reduced cell apoptosis by MTT assay, LDH assay, Hoechst 33258 dye staining, and FM also decreased the accumulation of reactive oxygen species (ROS) by DCFH-DA staining and NBT test. Furthermore, FM also reversed the upregulation of Bax/Bcl-2 ratio, the downstream cascade following ROS. FM protected PC12 cells from oxidative stress insult via downregulating the Bax/Bcl-2 ratio. These findings indicate that a direct effect of fasudil mesylate on PC12 cells may be partly responsible for its protective effect against oxidative stress injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21061151     DOI: 10.1007/s10571-010-9614-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  31 in total

Review 1.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

Review 2.  Regulation of apoptosis by Bcl-2 family proteins.

Authors:  Alexandrina Burlacu
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

Review 3.  Rho kinase, a promising drug target for neurological disorders.

Authors:  Bernhard K Mueller; Helmut Mack; Nicole Teusch
Journal:  Nat Rev Drug Discov       Date:  2005-05       Impact factor: 84.694

Review 4.  Mechanisms of ischemic brain damage.

Authors:  Kristian P Doyle; Roger P Simon; Mary P Stenzel-Poore
Journal:  Neuropharmacology       Date:  2008-01-25       Impact factor: 5.250

Review 5.  Neuronal death/survival signaling pathways in cerebral ischemia.

Authors:  Taku Sugawara; Miki Fujimura; Nobuo Noshita; Gyung Whan Kim; Atsushi Saito; Takeshi Hayashi; Purnima Narasimhan; Carolina M Maier; Pak H Chan
Journal:  NeuroRx       Date:  2004-01

6.  Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF.

Authors:  Jing Ding; Jie-Zhong Yu; Qin-Ying Li; Xin Wang; Chuan-Zhen Lu; Bao-Guo Xiao
Journal:  Brain Behav Immun       Date:  2009-05-15       Impact factor: 7.217

7.  Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation.

Authors:  Ting Wang; Jun Gu; Peng-Fei Wu; Fang Wang; Zhe Xiong; Yuan-Jian Yang; Wen-Ning Wu; Ling-Dan Dong; Jian-Guo Chen
Journal:  Free Radic Biol Med       Date:  2009-03-09       Impact factor: 7.376

8.  Involvement of Bcl-2 family in apoptosis and signal pathways induced by cigarette smoke extract in the human airway smooth muscle cells.

Authors:  Weihua Hu; Jungang Xie; Jianping Zhao; Yongjian Xu; Shifang Yang; Wang Ni
Journal:  DNA Cell Biol       Date:  2009-01       Impact factor: 3.311

9.  Improvement of cognitive deficit and neuronal damage in rats with chronic cerebral ischemia via relative long-term inhibition of rho-kinase.

Authors:  Lin Huang; Zhi He; Lianjun Guo; Hongxing Wang
Journal:  Cell Mol Neurobiol       Date:  2007-06-07       Impact factor: 5.046

10.  Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model.

Authors:  Shin-ichi Satoh; Yoshinori Toshima; Asako Hitomi; Ichiro Ikegaki; Minoru Seto; Toshio Asano
Journal:  Brain Res       Date:  2007-12-04       Impact factor: 3.252

View more
  1 in total

1.  Screen identifies fasudil as a radioprotector on human fibroblasts.

Authors:  Yanling Yao; Chen Chen; Zuchao Cai; Guochao Liu; Chenxia Ding; David Lim; Dong Chao; Zhihui Feng
Journal:  Toxicol Res (Camb)       Date:  2022-07-22       Impact factor: 2.680

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.